Renaissance Technologies’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Renaissance Technologies’s Portfolio NMRD Stock Details NMRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-37,876	Closed	-$173K	–	4583
2021 Q4	$173K	Sell	37,876 -48,624	-56%	-$262K	﹤0.01%	3562
2021 Q3	$520K	Buy	86,500 +57,674	+200%	+$415K	﹤0.01%	2876
2021 Q2	$298K	Buy	+28,826	New	+$275K	﹤0.01%	3149
2019 Q2	–	Sell	-3,464	Closed	-$36K	–	3804
2019 Q1	$36K	Buy	+3,464	New	+$36.5K	﹤0.01%	3375

Other funds holding NMRD

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Renaissance Technologies's NMRD Position: Q1 2022 in Review

Renaissance Technologies sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2022, closing a stake of 37,876 shares — an estimated $173K sold.

Renaissance Technologies first reported a position in NMRD in Q1 2019 and held it in 4 quarters. The position peaked at $520K in Q3 2021. 17 funds tracked by Wall St. Rank hold NMRD as of Q1 2022.

Renaissance Technologies reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Renaissance Technologies sold 37,876 Nemaura Medical, Inc. Common Stock shares in Q1 2022, an estimated $173K.
Renaissance Technologies first reported a position in Nemaura Medical, Inc. Common Stock in Q1 2019 and held it in 4 quarters.
Renaissance Technologies's Nemaura Medical, Inc. Common Stock position peaked at $520K in Q3 2021.
17 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2022.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.